CN Patent

CN107072204A — 用于减轻阿片类药物诱导型欣快症的系统和方法

Assigned to Purdue Pharma LP · Expires 2017-08-18 · 9y expired

What this patent protects

在某些实施方案中公开了一种减轻或预防阿片类药物诱导型欣快症的方法，所述方法包括向有需要的患者施用有效量的丁丙诺啡。

USPTO Abstract

在某些实施方案中公开了一种减轻或预防阿片类药物诱导型欣快症的方法，所述方法包括向有需要的患者施用有效量的丁丙诺啡。

Drugs covered by this patent

nalmefene-hydrochloride (NALMEFENE HYDROCHLORIDE)

Patent Metadata

Patent number: CN107072204A
Jurisdiction: CN
Classification: —
Expires: 2017-08-18
Drug substance claim: No
Drug product claim: No
Assignee: Purdue Pharma LP
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.